Frequency of Syndrome of Inappropriate Antidiuretic Hormone in Patients with Guillain-Barré Syndrome Presenting at Tertiary Care Hospital, Karachi
Antidiuretic Hormone in Guillain-Barré Syndrome Patients
DOI:
https://doi.org/10.54393/pjhs.v6i3.2925Keywords:
Guillain-Barré Syndrome, Syndrome of Inappropriate Antidiuretic Hormone, Hyponatremia, Neurological ComplicationsAbstract
Guillain-Barré Syndrome (GBS) is a condition that causes inflammation in the nerves and can sometimes lead to a problem called SIADH. SIADH happens when the body makes too much of a hormone that controls water balance, leading to low sodium levels in the blood. Objective: To determine the frequency of SIADH inpatients with GBS presenting at Tertiary Care Hospital, Karachi. Methods: This Cross-sectional study was conducted at Department of Neurology, Civil Hospital, Karachi, from 12-07-19 till 12-01-20. Total 119 GBS patients who met the inclusion criteria were included. A brief history was recorded, and demographic details were noted in the form. Numerical data were summarized using simple descriptive statistics. Categorical data were shown as numbers and percentages. Results: 71 (59.7%) were male and 48 (40.3%) were female. Mean age in the study was 46.78 ± 2.81 years. Whereas, Mean age, duration of symptoms, serum sodium and GC Sinour study was 46.78 ± 2.81 years, 25 ± 10.78 hours, 128.65 ± 7.52 mmol/L and 11.21 ± 3.14 % respectively. Out of 119 GBS patients, 21% had SIADH. Conclusions: This study showed that SIADH is present in significant proportion of patients with GBS. Thus, it is essential to focus on a comprehensive way of management of GBS and its comorbidities rather than primarily treating the neurological symptoms.
References
Kumar A, Kumar S, Sarkari M, Awasthi M. Electrophysiological subtypes of guillain-barré syndrome and its outcome in brd medical college, gorakhpur. International Journal of Academic Medicine and Pharmacy. 2024 Oct; 6(5): 616-9. doi: 10.47009/jamp.2024.6.5.116.
Kalita J, Kumar M, Misra UK. Prospective comparison of acute motor axonal neuropathy and acute inflammatory demyelinating polyradiculoneuropathy in 140 children with Guillain-Barré syndrome in India. Muscle & Nerve. 2018 May; 57(5): 761-5. doi: 10.1002/mus.25992. DOI: https://doi.org/10.1002/mus.25992
Elendu C, Osamuyi EI, Afolayan IA, Opara NC, Chinedu-Anunaso NA, Okoro CB et al. Clinical presentation and symptomatology of Guillain-Barré syndrome: A literature review. Medicine. 2024 Jul; 103(30): e38890. doi: 10.1097/MD.0000000000038890. DOI: https://doi.org/10.1097/MD.0000000000038890
National Institute of Neurological Disorders and Stroke (NINDS). Guillain-Barré Syndrome [Internet]. Bethesda (MD): National Institutes of Health; [updated 2024; cited 2024 Dec 19]. Available from: https://www.ninds.nih.gov/health-information/disorders/guillain-barre-syndrome.
Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-barré syndrome. The lancet. 2021 Mar; 397(10280): 1214-28. doi: 10.1016/S0140-6736(21)00517-1. DOI: https://doi.org/10.1016/S0140-6736(21)00517-1
Tajwar S. Developing syndrome of inappropriate antidiuretic hormone secretion in Guillain-Barre syndrome. Open Health. 2024 Dec; 5(1): 20230051. DOI: https://doi.org/10.1515/ohe-2023-0051
Hamed SA. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies. Expert Review of Clinical Pharmacology. 2019 Jan; 12(1): 61-90. doi: 10.1080/17512433.2019.1555468. DOI: https://doi.org/10.1080/17512433.2019.1555468
Ogawa S, Hosokawa T, Hayakawa C, Sawai T, Kakiuchi K, Nishioka D et al. Risk factors and outcome of hyponatremia in patients with Guillain-Barré syndrome. Scientific Reports. 2024 Jul; 14(1): 16664. doi: 10.1038/s41598-024-67427-6. DOI: https://doi.org/10.1038/s41598-024-67427-6
Long MT, Leiendecker ER, Dollerschell JT, Tokarcyzk A, Coursin DB. Endocrine Issues in Neurocritical Care. InTextbook of Neurointensive Care: Volume 1: Neuroanatomy, Diagnostic Assessment, Disease Management 2024 Oct: 603-625. doi: 10.1007/978-3-031-62220-5_35. DOI: https://doi.org/10.1007/978-3-031-62220-5_35
Hazou CL, Martinez RA, García GM. ¿ Guillain Barre syndrome and inadequate secretion of antidiuretic hormone, is their relationship possible?. Multidisciplinar (Montevideo). 2024(2): 3. DOI: https://doi.org/10.62486/agmu202447
Kamel MH, Upadhyay A, Borkan SC. Intractable hyponatremia complicated by a reset osmostat: a case report. Journal of Medical Case Reports. 2023 Jan; 17(1): 13. doi: 10.1186/s13256-022-03732-w. DOI: https://doi.org/10.1186/s13256-022-03732-w
Somaili M. Coronavirus 19 (COVID-19) and Syndrome of Inappropriate Anti-Diuretic Hormone Secretion (SIADH): A Review of Literature. Post COVID-19-Effects on Human Health. 2023 Mar. doi: 10.5772/intechopen.110717. DOI: https://doi.org/10.5772/intechopen.110717
Miyata S. Glial functions in the blood-brain communication at the circumventricular organs. Frontiers in Neuroscience. 2022 Oct; 16: 991779. doi: 10.3389/fnins.2022.991779. DOI: https://doi.org/10.3389/fnins.2022.991779
Zammar K, Al-Emadi A, Safan A, Mesraoua B, Melikyan G. Ciprofloxacin induced Guillain-Barre Syndrome, Posterior reversible Encephalopathy Syndrome, Hepatotoxicity, and Syndrome of Inappropriate Antidiuretic Hormone Secretion, A Case Report. 2024 May. doi: 10.21203/rs.3.rs-4763899/v1 DOI: https://doi.org/10.21203/rs.3.rs-4763899/v1
Saifudheen K, Jose J, Gafoor VA, Musthafa M. Guillain-Barre syndrome and SIADH. Neurology. 2011 Feb; 76(8): 701-4. doi: 10.1212/WNL.0b013e31820d8b40. DOI: https://doi.org/10.1212/WNL.0b013e31820d8b40
Sentíes-Madrid H, Domínguez-Moreno R, Tolosa-Tort P, Patiño-Tamez A, Quintero-Bauman A, Collado-Frías DK, Miranda-Rodríguez MG et al. Mortality associated with a diagnosis of Guillain-Barré syndrome in adults of Mexican health institutions. Revista de neurologia. 2014 Jan; 58(1): 4-10. doi: 10.33588/rn.5801.2013370. DOI: https://doi.org/10.33588/rn.5801.2013370
Malaga M, Rodriguez-Calienes A, Velasquez-Rimachi V, Alva-Diaz C. Diagnosis of Guillain-Barré syndrome and use of Brighton criteria in Peruvian hospitals. Arquivos de Neuro-psiquiatria. 2022 Jun; 80(06): 601-6. doi: 10.1590/0004-282x-anp-2021-0225. DOI: https://doi.org/10.1590/0004-282x-anp-2021-0225
Santoro C, Guerra T, D'Errico E, Fraddosio A, Lapenna F, Introna A et al. Guillain‐Barré syndrome associated with inappropriate secretion of antidiuretic hormone following SARS‐CoV‐2 infection: A case‐report. Clinical Case Reports. 2021 Oct; 9(10): e04667. doi: 10.1002/ccr3.4667. DOI: https://doi.org/10.1002/ccr3.4667
James J and Jose J. Syndrome of inappropriate secretion of antidiuretic hormone preceding Guillain-Barré syndrome. Journal of Clinical and Diagnostic Research. 2017 Sep; 11(9): OD16. doi: 10.7860/JCDR/2017/30445.10662. DOI: https://doi.org/10.7860/JCDR/2017/30445.10662
Shah PM, Dhakre VW, Veerasuri R, Bhabhor A. Dysautonomia and hyponatraemia as harbingers of Guillain-Barre syndrome. British Medical Journal Case Reports CP. 2019 Apr; 12(4): e226925. doi: 10.1136/bcr-2018-226925. DOI: https://doi.org/10.1136/bcr-2018-226925
Martínez-Piña DA, Medina-Gómez V, García-Hernández JF, Vargas-Cañas ES, Violante-Villanueva A, López-Hernández JC. Guillain-Barre syndrome with hyponatremia, more than a simple finding. Revista mexicana de neurociencia. 2023 Jun; 24(3): 71-7. dsoi: 10.24875/RMN.22000081. DOI: https://doi.org/10.24875/RMN.22000081
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
